Medtronic Cardiovascular — Total Assets increased by 0.5% to $16.75B in Q1 2026 compared to the prior quarter.
An increase suggests capital expansion or investment in cardiovascular manufacturing and R&D, while a decrease may indicate asset divestiture, depreciation, or a shift in strategic focus away from this segment.
This metric represents the total carrying value of assets specifically allocated to the cardiovascular business segment,...
Peers in the medical device industry report similar segment-level asset allocations to track capital intensity and return on invested capital within specific therapeutic areas.
mdt_segment_cardiovascular_total_assets| Q2 '21 | Q2 '22 | Q2 '23 | Q2 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $15.03B | $14.49B | $16.05B | $16.13B | $16.55B | $16.57B | $16.66B | $16.75B |
| QoQ Change | — | -3.6% | +10.8% | +0.5% | +2.6% | +0.2% | +0.5% | +0.5% |
| YoY Change | — | -3.6% | +10.8% | +0.5% | +2.6% | — | — | — |